Arcus Biosciences (RCUS) Operating Income Growth (1y) (2018 - 2026)
Arcus Biosciences (RCUS) Operating Income Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.75 Bn | 467.96 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 122.14 Bn | 114.89 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn | 145.20% |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn | 1,386.07% |
| 10 | Arcus Biosciences | 3.53 Bn | 2.71 Bn | - | -9.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.84% |
| Dec 31, 2025 | -10.68% |
| Sep 30, 2025 | -35.24% |
| Jun 30, 2025 | 92.45% |
| Mar 31, 2025 | -662.50% |
| Dec 31, 2024 | -13.19% |
| Sep 30, 2024 | -31.25% |
| Jun 30, 2024 | -27.71% |
| Mar 31, 2024 | 81.40% |
| Dec 31, 2023 | -22.97% |
| Sep 30, 2023 | -14.29% |
| Jun 30, 2023 | -20.29% |
| Mar 31, 2023 | -28.36% |
| Dec 31, 2022 | -126.33% |
| Sep 30, 2022 | 10.41% |
| Jun 30, 2022 | 9.37% |
| Mar 31, 2022 | 7.90% |
| Dec 31, 2021 | 642.75% |
| Sep 30, 2021 | -5,134.54% |
| Jun 30, 2021 | -67.79% |